Xenetic Biosciences and Santersus AG sign definitive share exchange agreement

Xenetic Biosciences and Santersus AG announced a definitive share exchange agreement that would combine the two companies into what they describe as a global leader in NET-targeting therapeutics. The transaction is structured as a share exchange.

Detected & updated continuously · Source: Nebula